Aydin U, Yazici P, Sozbilen M, Kece C, Tamsel S, Kilic M
Ege University School of Medicine, Organ Transplantation and Research Center, Izmir, Turkey.
Transplant Proc. 2007 Jun;39(5):1688-90. doi: 10.1016/j.transproceed.2006.11.025.
Hepatocellular cancer (HCC) is the most common primary malignant hepatic tumor that accounts for over 80% of primary liver tumors. Hepatic resection is a well-accepted therapy for HCC, but 70% to 100% of patients, depending on patient selection, baseline tumor characteristics, and follow-up duration, develop cancer recurrence after resective surgery. Orthotropic liver transplantation is considered more appropriate in cases with HCC related to cirrhosis. Both procedures may result in recurrence. In some cases, diagnosis of recurrent HCC is difficult because of unexpected localization of the tumor. For these patients, aggressive diagnostic tests might be useful for appropriate therapy. We report a case of a 48-year-old man undergoing resection for HCC, who experienced early recurrence of HCC in the pelvic region.
肝细胞癌（HCC）是最常见的原发性恶性肝肿瘤，占原发性肝肿瘤的80%以上。肝切除术是一种被广泛接受的HCC治疗方法，但根据患者选择、基线肿瘤特征和随访时间的不同，70%至100%的患者在切除术后会发生癌症复发。对于与肝硬化相关的HCC病例，原位肝移植被认为更为合适。这两种手术都可能导致复发。在某些情况下，由于肿瘤的意外定位，复发性HCC的诊断很困难。对于这些患者，积极的诊断测试可能有助于进行适当的治疗。我们报告一例48岁接受HCC切除术的男性患者，其在盆腔区域出现了HCC早期复发。
